ダウンロード数: 206

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
srep42888.pdf1.93 MBAdobe PDF見る/開く
タイトル: Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells
著者: Sun, Michael
Ha, Ngoc
Pham, Duc-Hung
Frederick, Megan
Sharma, Bandana
Naruse, Chie  kyouindb  KAKEN_id
Asano, Masahide  kyouindb  KAKEN_id
Pipkin, Matthew E.
George, Rani E.
Thai, To-Ha
著者名の別形: 浅野, 雅秀
発行日: 21-Feb-2017
出版者: Springer Nature
誌名: Scientific Reports
巻: 7
論文番号: 42888
記述: Cbx3/HP1γ is a histone reader whose function in the immune system is not completely understood. Here, we demonstrate that in CD8+ T cells, Cbx3/HP1γ insufficiency leads to chromatin remodeling accompanied by enhanced Prf1, Gzmb and Ifng expression. In tumors obtained from Cbx3/HP1γ- insufficient mice or wild type mice treated with Cbx3/HP1γ-insufficient CD8+ T cells, there is an increase of CD8+ effector T cells expressing the stimulatory receptor Klrk1/NKG2D, a decrease in CD4+ CD25+ FOXP3+ regulatory T cells (Treg cells) as well as CD25+ CD4+ T cells expressing the inhibitory receptor CTLA4. Together these changes in the tumor immune environment may have mitigated tumor burden in Cbx3/HP1γ-insufficient mice or wild type mice treated with Cbx3/HP1γ-insufficient CD8+ T cells. These findings suggest that targeting Cbx3/HP1γ can represent a rational therapeutic approach to control growth of solid tumors.
著作権等: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
URI: http://hdl.handle.net/2433/218632
DOI(出版社版): 10.1038/srep42888
PubMed ID: 28220815
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。